outcome of the Board meeting- Q1 Financial results

www.capillarytech.com Date: August 04, 2026 To To, BSE Limited National Stock Exchange of India Limited Listing Department Listing Department Phiroze JeeJeebhoy Towers, Dalal Exchange Plaza , Bandra Kurla Complex Street Fort, Mumbai -400001 Bandra (East), Mumbai -4000051 Scrip Code: 544614 Symbol: CAPILLARY Dear Sir/Madam Subject: Outcome of Board Meeting held on August 04, 2026. Pursuant to Regulation 30, 33 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors of Capillary Technologies India Limited (“the Company”) at its meeting held today i.e., August 04, 2026, inter-alia, has considered and approved unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026 (“Financial Results”) along with the Limited Review Report. A copy of Financial Results, along with the Limited Review Report is enclosed. The Meeting of the board of directors of the Company commenced at 10:30 AM (IST) and concluded at 1:05 PM (IST). Further, in continuation to our earlier intimation dated June 26, 2026, regarding closure of trading window, we wish to inform you that trading window for dealing in the securities of the Company has been closed from July 01, 2026, and shall re-open after 48 hours from the declaration of the financial results of the Company. This outcome of Board Meeting will also be made available on the website of the Company at: https://www.capillarytech.com/investors/ We request you to take the above information on records. Yours faithfully, For Capillary Technologies India Limited Gireddy Bhargavi Reddy Company Secretary and Compliance Officer Membership No. A17091 Place: Bengaluru Capillary Technologies India Limited CIN- L72200KA2012PLC063060 Regd. Office - 360, bearing PID No: 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru, Karnataka 560102 Email: secretarial@capillarytech.com Website: www.capillarytech.com Tel: 080-41225179 Walker Chandiok & Co LLP 5th Floor, 65/2, Block “A”, Bagmane Tridib, Bagmane Tech Park, CV Raman Nagar, Bengaluru 560093 Karnataka, India T +91 80 4243 0700 F +91 80 4126 1228 Independent Auditor’s Review Report on the Standalone Unaudited Quarterly Financial Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Capillary Technologies India Limited 1. We have reviewed the accompanying statement of the standalone unaudited financial results (‘the Statement’) of Capillary Technologies India Limited (‘the Company’) for the quarter ended 30 June 2026 being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (‘Listing Regulations’). Attention is drawn to the fact that the figures for the corresponding quarter ended 30 June 2025 have been approved by the Company’s Board of Directors, but have not been subjected to audit or review. 2. The Statement, which is the responsibility of the Company’s management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (‘Ind AS 34’), prescribed under Section 133 of the Companies Act, 2013 (‘the Act’), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under Section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Chartered Accountants Walker Chandiok & Co LLP is registered with limited liability with identification Offices in Ahmedabad, Bengaluru, Chandigarh, Chennai, Dehradun, Goa, Gurugram, Hyderabad, Indore, Kochi, Kolkata, Mumbai, number AAC-2085 and has its registered New Delhi, Noida and Pune office at L-41 Connaught Circus, Outer Circle, New Delhi, 110001, India 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under Section 133 of the Act, and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in accordance with the requirements of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Walker Chandiok & Co LLP Chartered Accountants Firm Registration No: 001076N/N500013 Aasheesh Arjun Singh Partner Membership No. 210122 UDIN: 26210122EKDBRO6296 Bengaluru 04 August 2026 Chartered Accountants Capillary Technologies India Limited CIN Number - L72200KA2012PLC063060 Registered Office: #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Phone No. +91 80 4122 5179 Website : www.capillarytech.com E-mail: investorrelations@capillarytech.com (All amounts in Indian Rupees (₹) million, except per share data) Statement of Standalone Unaudited Financial Results for the Quarter Ended 30 June 2026 Particulars Quarter Ended Year Ended 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26 (Unaudited) (Audited) (Unaudited) (Audited) (Refer note 2) (Refer note 3) (Refer note 4) Income IRevenue from operations 642.87 650.23 423.25 2,118.90 IIOther income 4 6.65 56.18 4.58 105.78 IIITotal income (I+II) 689.52 706.41 427.83 2 ,224.68 IVExpenses - Professional and consultancy expenses 6 5.03 49.60 5 7.66 213.89 - Software and server charges 3 2.87 35.32 2 6.86 110.65 - Employee benefit expense (Refer note 6) 347.23 364.68 254.81 1,225.96 - Other expenses (Refer note 7) 4 7.19 39.44 2 7.48 174.24 Total expenses 492.32 489.04 366.81 1 ,724.74 VProfit before finance costs, depreciation, amortization and tax expense 197.20 2 17.37 6 1.02 499.94 (III-IV) - Depreciation and amortisation expenses 111.92 110.50 105.29 434.56 - Finance costs 7.63 7 .92 6.94 36.48 VIProfit/ (loss) before exceptional items and tax 7 7.65 98.95 (51.21) 28.90 VIIExceptional items - - - - VIIIProfit/ (loss) before tax (VI-VII) 7 7.65 98.95 (51.21) 28.90 IXTax expense/ (credit) - Current tax - - - - - Deferred tax - - - - Total tax expense - - - - XProfit/ (loss) after tax (VIII-IX) 7 7.65 98.95 (51.21) 28.90 Other Comprehensive income/ (loss) (a) Items that will not to be reclassified to the statement of profit or loss: -Re-measurement of defined benefit plan, net of tax ( 0.30) 1 .10 ( 0.69) (1.19) XIOther comprehensive (loss)/ income, net of tax (0.30) 1.10 (0.69) (1.19) XIITotal comprehensive income/ (loss) (X+XI) 7 7.35 100.05 (51.90) 27.71 Paid-up equity share capital 158.94 158.81 146.65 158.81 Other equity 8,073.23 Earnings per equity share (face value ₹ 2 each)* (a) Basic (in ₹ per share) 0.98 1 .25 ( 0.70) 0 .38 (b) Diluted (in ₹ per share) 0.97 1 .23 ( 0.70) 0 .38 * Earnings/ (loss) per share data for the quarters is not annualised. Se [Showing first 8,000 characters — download PDF for full document]